{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:00:18Z","timestamp":1787022018035,"version":"build-2736575974"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wenling science and technology project fund","award":["2012WLCA0057"],"award-info":[{"award-number":["2012WLCA0057"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0191951","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T13:34:16Z","timestamp":1517232856000},"page":"e0191951","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["The timing of azithromycin treatment is not associated with the clinical prognosis of childhood Mycoplasma pneumoniae pneumonia in high macrolide-resistant prevalence settings"],"prefix":"10.1371","volume":"13","author":[{"given":"Dehua","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5160-7502","authenticated-orcid":true,"given":"Zhimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"issue":"4","key":"ref1","first-page":"697","article-title":"Mycoplasma pneumoniae and its role as a human pathogen[J]","volume":"17","author":"KB Waites","year":"2004","journal-title":"ClinMicrobiol Rev"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1542\/peds.113.4.701","article-title":"Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children[J]","volume":"113","author":"IC Michelow","year":"2004","journal-title":"Pediatrics"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jhm.1904","article-title":"Macrolide therapy and outcomes in a multicenter cohort of children hospitalized with Mycoplasma pneumoniae pneumonia[J]","volume":"7","author":"SS Shah","year":"2012","journal-title":"J Hosp Med"},{"key":"ref4","first-page":"307","article-title":"Macrolide use shortens fever duration in Mycoplasma pneumoniae infection in children: a 2-year experience[J]","volume":"41","author":"YJ Lu","year":"2008","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.inf.0000160949.99560.8d","article-title":"Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections[J]","volume":"24","author":"S Esposito","year":"2005","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10180","article-title":"Comparative randomized trial of azithromycin versus erythromycin and amoxycillin for treatment of community-acquired pneumonia in children[J]","volume":"35","author":"R Kogan","year":"2003","journal-title":"Pediatric Pulmonology"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.05.20073-en","article-title":"Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011[J]","volume":"17","author":"SA Uldum","year":"2012","journal-title":"Euro Surveill"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1128\/AAC.49.6.2302-2306.2005","article-title":"Emargence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation[J]","volume":"49","author":"M Morozumi","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10156-009-0021-4","article-title":"Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia[J]","volume":"16","author":"M Morozumi","year":"2010","journal-title":"Infect Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/cis784","article-title":"Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children[J]","volume":"56","author":"T Okada","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"ref11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/cid\/cir1065","article-title":"The definition of pneumonia, the assessment of severity, and clinical standardization in the Pneumonia Etiology Research for Child Health study[J]","volume":"54","author":"JA Scott","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ppul.20988","article-title":"Severity of childhood community-acquired pneumonia and chest radiographic findings[J]","volume":"44","author":"N Kin Key","year":"2009","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/INF.0b013e3181c2a1b9","article-title":"Clinical presentation and severity of viral community-acquired pneumonia in young Nepalese children[J]","volume":"29","author":"M Mathisen","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1542\/peds.2013-3729","article-title":"Treatment of mycoplasma pneumonia: a systematic review[J]","volume":"133","author":"E Biondi","year":"2014","journal-title":"Pediatrics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1128\/AAC.50.2.709-712.2006","article-title":"Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae[J]","volume":"50","author":"S Suzuki","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10156-009-0715-7","article-title":"A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients[J]","volume":"15","author":"K Matsubara","year":"2009","journal-title":"Infect Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/cis784","article-title":"Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children[J]","volume":"56","author":"T Okada","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jinf.2008.06.012","article-title":"Methylprednisolone pulse therapy for refractory Mycopplasma pneumoniae pneumonia in children[J]","volume":"57","author":"A Tamura","year":"2008","journal-title":"J Infect"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1086\/317498","article-title":"Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment[J]","volume":"31","author":"M Radisic","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1128\/AAC.49.6.2302-2306.2005","article-title":"Emargence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation[J]","volume":"49","author":"M Morozumi","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1128\/AAC.01684-08","article-title":"Antimicrobial suscepetibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant from Shanghai, China[J]","volume":"53","author":"Y Liu","year":"2009","journal-title":"Antimicrob Agents Chenother"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/AAC.01806-13","article-title":"More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia[J]","volume":"58","author":"Y Zhou","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/AAC.01563-08","article-title":"Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China[J]","volume":"53","author":"D Xin","year":"2009","journal-title":"Antimicrob Agents Chenother"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1128\/JCM.00400-12","article-title":"Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands[J]","volume":"50","author":"EB Spuesens","year":"2012","journal-title":"Clin. Microbiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/1469-0691.12107","article-title":"The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains[J]","volume":"19","author":"S Pereyre","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/INF.0b013e318247f3e0","article-title":"Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States[J]","volume":"31","author":"M Yamada","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/rccm.200601-071OC","article-title":"Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome[J]","volume":"174","author":"GM Verleden","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1203\/PDR.0b013e318142582d","article-title":"Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants[J]","volume":"62","author":"ZH Aghai","year":"2007","journal-title":"Pediatr Res"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2249.2007.03299.x","article-title":"Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells[J]","volume":"147","author":"K Sugiyama","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0014-2999(01)01321-8","article-title":"Anti-inflammatory effects of macrolide antibiotics[J]","volume":"429","author":"O Culic","year":"2001","journal-title":"Eur J Pharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0191951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:54:31Z","timestamp":1540032871000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0191951"}},"subtitle":[],"editor":[{"given":"Senthilnathan","family":"Palaniyandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,29]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0191951","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,29]]}}}